Pharmabiz46m
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...
Pharmabiz2h
Annoyed over Union health ministry decision, BDPMA to approach state govt for support of local pharma companies
Annoyed over Union health ministry decision, BDPMA to approach state govt for support of local pharma companies: Peethaambaran Kunnathoor, Chennai Saturday, February 15, 2025, 08: ...
Pharmabiz2h
Seeking comments from industry on extension of revised Schedule M deadline was a fruitless exercise: Industry
Gireesh Babu, New Delhi Saturday, February 15, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Future of dentistry driven by tech as online dental marketplaces gain ground: Dr Vikas Agarwal
Future of dentistry driven by tech as online dental marketplaces gain ground: Dr Vikas Agarwal: Nandita Vijayasimha, Bengaluru Saturday, February 15, 2025, 08:00 Hrs [IST] Dentist ...
Pharmabiz2h
Budget 2025 unveils major boost for small businesses to strengthen pharma MSME exports
Budget 2025 unveils major boost for small businesses to strengthen pharma MSME exports: Shardul Nautiyal, Mumbai Saturday, February 15, 2025, 08:00 Hrs [IST] The Union Budget 2025 ...
Pharmabiz2h
Healthcare and medical services are primary focus in KWIN City, Karnataka
Healthcare and medical services are primary focus in KWIN City, Karnataka: Nandita Vijayasimha, Bengaluru Saturday, February 15, 2025, 08:00 Hrs [IST] Karnataka’s KWIN (Knowledg ...
Pharmabiz17h
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Pharmabiz18h
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...
Pharmabiz18h
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...
Pharmabiz19h
Santhera announces agreement with German GKV-SV on reimbursement for Agamree to treat Duchenne muscular dystrophy
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Pharmabiz17h
Tivic Health acquires exclusive global rights to TLR5 agonist Entolimod from Statera Biopharma to treat acute radiation syndrome
Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...
Pharmabiz18h
Rusan Pharma’s chairman Dr Navin Saxena conferred with Russia’s prestigious ‘Order of Friendship’ and ‘Academic Honour’
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, has been honoured with two of Russia’s most distinguished accolades, ‘The ...